| Christopher Steven English, MD | |
|
1551 Renaissance Towne Dr Ste 400, Bountiful, UT 84010-7676 | |
| (801) 295-7200 | |
| (801) 295-4930 |
| Full Name | Christopher Steven English |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 16 Years |
| Location | 1551 Renaissance Towne Dr Ste 400, Bountiful, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538331871 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 9074570-1205 (Utah) | Secondary |
| 207X00000X | Orthopaedic Surgery | 9074570-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Layton Hospital | Layton, UT | Hospital |
| Davis Hospital And Medical Center | Layton, UT | Hospital |
| Lakeview Hospital | Bountiful, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain Orthopaedics Llc | 7113282179 | 20 |
News Archive
The Federal Trade Commission (FTC) and the Food and Drug Administration (FDA), working with government agencies in Mexico and Canada, have launched a drive to stop deceptive Internet advertisements and sales of products misrepresented as cures or treatments for diabetes.
The experimental "smart-bomb" drug rovalpituzumab tesirine (Rova-T) appears safe and shows efficacy in treating patients with advanced small cell lung cancer (SCLC), according to results from a first-in-human clinical trial to be presented today by a Memorial Sloan Kettering Cancer Center researcher at the 2016 American Society of Clinical Oncology Annual Meeting in Chicago.
Public opinions have changed since President Bill Clinton tried to reform the health care system more than a a decade ago. USA Today reports that "the years since Clinton's failed effort have seen the cost of medical services nearly double and softened some of the skepticism voiced by Americans in 1993 and 1994. The percentage who say Congress should pass comprehensive legislation, rather than dealing with health care incrementally over several years, has increased by 10 points, USA TODAY/Gallup Polls show."
Building on their recent research focusing on a peptide, pNaKtide, designed to block the oxidant amplifying function of the cellular sodium-potassium pump, researchers at Marshall University Joan C. Edwards School of Medicine have successfully demonstrated that pNaKtide, can attenuate the development of experimental nonalcoholic fatty liver disease (NAFLD) and atherosclerosis.
› Verified 8 days ago
| Entity Name | Christopher S English, Md, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467048082 PECOS PAC ID: 2466866520 Enrollment ID: O20210201001127 |
News Archive
The Federal Trade Commission (FTC) and the Food and Drug Administration (FDA), working with government agencies in Mexico and Canada, have launched a drive to stop deceptive Internet advertisements and sales of products misrepresented as cures or treatments for diabetes.
The experimental "smart-bomb" drug rovalpituzumab tesirine (Rova-T) appears safe and shows efficacy in treating patients with advanced small cell lung cancer (SCLC), according to results from a first-in-human clinical trial to be presented today by a Memorial Sloan Kettering Cancer Center researcher at the 2016 American Society of Clinical Oncology Annual Meeting in Chicago.
Public opinions have changed since President Bill Clinton tried to reform the health care system more than a a decade ago. USA Today reports that "the years since Clinton's failed effort have seen the cost of medical services nearly double and softened some of the skepticism voiced by Americans in 1993 and 1994. The percentage who say Congress should pass comprehensive legislation, rather than dealing with health care incrementally over several years, has increased by 10 points, USA TODAY/Gallup Polls show."
Building on their recent research focusing on a peptide, pNaKtide, designed to block the oxidant amplifying function of the cellular sodium-potassium pump, researchers at Marshall University Joan C. Edwards School of Medicine have successfully demonstrated that pNaKtide, can attenuate the development of experimental nonalcoholic fatty liver disease (NAFLD) and atherosclerosis.
› Verified 8 days ago
| Entity Name | Mountain Orthopaedics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952019846 PECOS PAC ID: 7113282179 Enrollment ID: O20230324001349 |
News Archive
The Federal Trade Commission (FTC) and the Food and Drug Administration (FDA), working with government agencies in Mexico and Canada, have launched a drive to stop deceptive Internet advertisements and sales of products misrepresented as cures or treatments for diabetes.
The experimental "smart-bomb" drug rovalpituzumab tesirine (Rova-T) appears safe and shows efficacy in treating patients with advanced small cell lung cancer (SCLC), according to results from a first-in-human clinical trial to be presented today by a Memorial Sloan Kettering Cancer Center researcher at the 2016 American Society of Clinical Oncology Annual Meeting in Chicago.
Public opinions have changed since President Bill Clinton tried to reform the health care system more than a a decade ago. USA Today reports that "the years since Clinton's failed effort have seen the cost of medical services nearly double and softened some of the skepticism voiced by Americans in 1993 and 1994. The percentage who say Congress should pass comprehensive legislation, rather than dealing with health care incrementally over several years, has increased by 10 points, USA TODAY/Gallup Polls show."
Building on their recent research focusing on a peptide, pNaKtide, designed to block the oxidant amplifying function of the cellular sodium-potassium pump, researchers at Marshall University Joan C. Edwards School of Medicine have successfully demonstrated that pNaKtide, can attenuate the development of experimental nonalcoholic fatty liver disease (NAFLD) and atherosclerosis.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Steven English, MD 1551 Renaissance Towne Dr Ste 400, Bountiful, UT 84010-7676 Ph: (801) 295-7200 | Christopher Steven English, MD 1551 Renaissance Towne Dr Ste 400, Bountiful, UT 84010-7676 Ph: (801) 295-7200 |
News Archive
The Federal Trade Commission (FTC) and the Food and Drug Administration (FDA), working with government agencies in Mexico and Canada, have launched a drive to stop deceptive Internet advertisements and sales of products misrepresented as cures or treatments for diabetes.
The experimental "smart-bomb" drug rovalpituzumab tesirine (Rova-T) appears safe and shows efficacy in treating patients with advanced small cell lung cancer (SCLC), according to results from a first-in-human clinical trial to be presented today by a Memorial Sloan Kettering Cancer Center researcher at the 2016 American Society of Clinical Oncology Annual Meeting in Chicago.
Public opinions have changed since President Bill Clinton tried to reform the health care system more than a a decade ago. USA Today reports that "the years since Clinton's failed effort have seen the cost of medical services nearly double and softened some of the skepticism voiced by Americans in 1993 and 1994. The percentage who say Congress should pass comprehensive legislation, rather than dealing with health care incrementally over several years, has increased by 10 points, USA TODAY/Gallup Polls show."
Building on their recent research focusing on a peptide, pNaKtide, designed to block the oxidant amplifying function of the cellular sodium-potassium pump, researchers at Marshall University Joan C. Edwards School of Medicine have successfully demonstrated that pNaKtide, can attenuate the development of experimental nonalcoholic fatty liver disease (NAFLD) and atherosclerosis.
› Verified 8 days ago
Robert W Jordan, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1551 S Renaissance Towne Dr, #400, Bountiful, UT 84010 Phone: 801-295-7200 Fax: 801-295-4930 | |
Paul Johnson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1551 Renaissance Towne Dr Ste 400, Bountiful, UT 84010 Phone: 801-295-7200 Fax: 801-295-4930 | |
Lyle Beyer Mason, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1708 Stone Ridge Cir, Bountiful, UT 84010 Phone: 801-295-7604 Fax: 801-295-7604 | |
Travis M Hendry, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1551 Renaissance Towne Dr Ste 400, Bountiful, UT 84010 Phone: 801-295-7200 Fax: 801-295-4930 | |
Ryan Paul Rigby, Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1551 Renaissance Towne Dr Ste 400, Bountiful, UT 84010 Phone: 801-712-4204 Fax: 801-295-4930 | |
R Pepper Murray, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1551 Renaissance Towne Dr, Ste. 400, Bountiful, UT 84010 Phone: 801-295-7200 Fax: 801-295-4930 | |
Dr. Jared John Tyson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1551 Renaissance Towne Dr, Suite 400, Bountiful, UT 84010 Phone: 801-295-7200 Fax: 801-295-4930 |